Clinical trials
Phase 2 Emphysema trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
50 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 4 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 3 |
| 2009 | 6 |
| 2010 | 4 |
| 2011 | 2 |
| 2012 | 3 |
| 2014 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 1 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 40 |
| Active, not recruiting | 4 |
| Unknown status | 3 |
| Terminated | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 6 |
| Aeris Therapeutics | 4 |
| GlaxoSmithKline | 4 |
| Chelsea and Westminster NHS Foundation Trust | 2 |
| National Heart, Lung, and Blood Institute (NHLBI) | 2 |
| Sanofi | 2 |
| Sunovion Respiratory Development Inc. | 2 |
| US Department of Veterans Affairs | 2 |
| University of Alabama at Birmingham | 2 |
| Altesa Biosciences, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Emphysema | 50 |
| Pulmonary Disease, Chronic Obstructive | 42 |
| Bronchitis, Chronic | 15 |
| alpha 1-Antitrypsin Deficiency | 7 |
| Lung Diseases | 6 |
| Pulmonary Emphysema | 4 |
| Lung Diseases, Obstructive | 3 |
| Bronchiolitis Obliterans Syndrome | 2 |
| Bronchitis | 2 |
| Dyspnea | 2 |
Trials
Showing 26 to 50 of 50. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.